Pei-tzu WU,Jia-Hau SHIU,Madhu CHERUKURY,Tan NGUYEN,Kevin ZEN
申请号：
US16803561
公开号：
US20200181214A1
申请日:
2020.02.27
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present invention relates to a biologic that inhibits angiogenesis. In particular, the present invention relates to fusion proteins that inhibit the integrin activated pathway and one other angiogenic factor-activated pathway, the compositions of these fusion proteins, as well as methods for producing and using the same.
